financetom
Business
financetom
/
Business
/
China pushes insurers to invest billions in latest move to support market
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
China pushes insurers to invest billions in latest move to support market
Jan 22, 2025 10:08 PM

SHANGHAI/HONG KONG (Reuters) -China announced plans on Thursday to channel hundreds of billions of yuan annually into shares from state-owned insurers, in the government's latest effort to support equity markets.

Authorities will in the first half of this year call on insurers to invest at least 100 billion yuan ($13.75 billion) of long-term funds into stocks, China Securities Regulatory Commission head Wu Qing said at a press conference.

The regulators will encourage big state insurers to invest 30% of new annual premiums in A-shares, and encourage mutual funds to increase their A-share holdings' tradable market value by at least 10% annually over the next three years, Wu said.

"Medium- and long-term funds play a crucial role in the capital market as professional investors. They act as the 'ballast' and 'stabilizer' to ensure the market runs smoothly and remains healthy," he said.

These measures will channel "several hundred billion" into onshore stocks every year, and consolidate the positive trend of the capital market, he added.

The plan also involves guiding mutual fund managers to increase investments in their own equity products, cut fund sales fees and promote the development of exchange-traded fund products.

The CSI300 blue-chip index advanced 0.6% while the Shanghai Composite Index jumped 1% by midday break. Hong Kong's Hang Seng Index added 0.2%.

A gauge tracking insurers jumped 2.6% in morning trade, with China Life Insurance rallying 4.3%.

Beijing has been intensifying policy support to prop up the stock market, which is weighed down heavily by a long-running property crisis, deflationary pressure and geopolitical tension.

Six Chinese government agencies, including the central bank and the securities regulator, released on Wednesday a slew of measures to guide medium- and long-term funds into the capital market.

Authorities have also introduced swap and re-lending schemes totalling 800 billion yuan for stock purchases in September as well as guidelines on market capitalisation management to encourage companies to improve shareholder returns.

The latest plan announced Thursday mirrors previous calls to promote capital markets, said Ben Bennett, Asia-Pacific investment strategist at Legal And General Investment Management.

"It's not a big surprise, but nice to see some tangible policies. These things need to go hand in hand with stronger growth and earnings expectations to be fully effective."

Stock prices have been highly volatile since authorities signalled support. The benchmark stock index CSI 300 surged 35% in the two weeks after that first stimulus announcement but disappointment with the degree and pace of implementation has seen the CSI 300 index halve that gain since.

($1 = 7.2728 Chinese yuan)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
INmune Bio Says AD02 Trial for Alzheimer's Disease Reveals Strong Performance of EMACC Cognitive Measure
INmune Bio Says AD02 Trial for Alzheimer's Disease Reveals Strong Performance of EMACC Cognitive Measure
Sep 17, 2024
10:19 AM EDT, 09/17/2024 (MT Newswires) -- INmune Bio ( INMB ) said Tuesday that additional analysis from its AD02 phase 2 trial for Alzheimer's disease showed exceptional performance of the Early AD/MCI Alzheimer's Cognitive Composite, or EMACC, measure. The analysis revealed a highly significant correlation between baseline scores on EMACC and the Clinical Dementia Rating-Sum of Boxes, or CDR-SB,...
Capricor Therapeutics, Nippon Shinyaku Sign Binding Term Sheet for Commercialization of Duchenne Muscular Dystrophy Treatment in Europe
Capricor Therapeutics, Nippon Shinyaku Sign Binding Term Sheet for Commercialization of Duchenne Muscular Dystrophy Treatment in Europe
Sep 17, 2024
10:31 AM EDT, 09/17/2024 (MT Newswires) -- Capricor Therapeutics ( CAPR ) said Tuesday it signed a binding term sheet with Japanese pharmaceutical firm Nippon Shinyaku to commercialize and distribute Capricor's Duchenne muscular dystrophy treatment deramiocel in Europe. Capricor said the potential deal that the term sheet covers is similar to the existing commercialization and distribution agreements with Nippon Shinyaku...
Uber to roll out 'verified' rider badge, trip recording features in US
Uber to roll out 'verified' rider badge, trip recording features in US
Sep 17, 2024
Sept 17 (Reuters) - Uber ( UBER ) is rolling out features that would allow its drivers to see verified badges on customer profiles and record trips on their smartphones instead of a dashcam, the ride-hailing firm said on Tuesday. This is expected to improve safety of drivers and comes against the backdrop of a 2021-22 safety report by Uber...
Intel Updates Viewed in 'Positive Light' But Not Sufficient to Overcome Challenges, Truist Says
Intel Updates Viewed in 'Positive Light' But Not Sufficient to Overcome Challenges, Truist Says
Sep 17, 2024
10:20 AM EDT, 09/17/2024 (MT Newswires) -- Intel's ( INTC ) recent business update announcements are viewed in a positive light but are not sufficient to overcome issues the company is facing, Truist Securities said in a note Tuesday. The highlights include Intel Foundry operating as an independent unit; the company receiving up to $3 billion in US government chip...
Copyright 2023-2025 - www.financetom.com All Rights Reserved